Comparison of the Dual Task, Cognitive Skills and Physical Activity With Problematic Game Players and Control Subjects

April 27, 2021 updated by: Cagtay Maden, Çağtay Maden
This study was conducted to compare the cognitive skills, dual-task and physical activity status of individuals who play problem video games and healthy individuals, and to determine how much these skills are affected. The cognitive skills of individuals with video game playing problems and the control group were evaluated with the Montreal Cognitive Assessment Test, the Trail Making Test A & B sections, and the Stroop test. I evaluated dual tasks with 10-meter walking test (single-double task) and Time Up and Go Test (single-double task). Physical activity levels were evaluated by International Physical Active Questionnaire. The average cognitive skills, dual tasks, and physical activity levels of the individuals in both groups were compared.

Study Overview

Status

Status

Indicates the current recruitment status or the expanded access status.
Completed

Conditions

Conditions

The disease, disorder, syndrome, illness, or injury that is being studied. On ClinicalTrials.gov, conditions may also include other health-related issues, such as lifespan, quality of life, and health risks.

Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.

Study Type

Study Type

Describes the nature of a clinical study. Study types include interventional studies (also called clinical trials), observational studies (including patient registries), and expanded access.
Observational

Enrollment (Actual)

Enrollment

The number of participants in a clinical study. The "anticipated" enrollment is the target number of participants that the researchers need for the study.
60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Turkey
    • Şahinbey
      • Gaziantep, Şahinbey, Turkey
        • Hasan Kalyoncu Universty

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Eligibility Criteria

The key requirements that people who want to participate in a clinical study must meet or the characteristics they must have. Eligibility criteria consist of both inclusion criteria (which are required for a person to participate in the study) and exclusion criteria (which prevent a person from participating). Types of eligibility criteria include whether a study accepts healthy volunteers, has age or age group requirements, or is limited by sex.

Ages Eligible for Study

18 years to 35 years (Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

University students in Hasan Kalyoncu University

Description

Inclusion Criteria:

  • DSM V (Diagnostic and Statistical Manual of Mental Disorders, revision 5) Internet Gaming Disorder (IOOB) Diagnostic criteria: Providing 5 out of 9 items
  • No communication barrier
  • To volunteer to participate in research
  • Be playing games at least 2 hours a day in the last year

Exclusion Criteria:

  • 3 days a week to be doing any sports
  • Having a chronic illness
  • Psychological disease diagnosis

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort

Group / Cohort

A group or subgroup of participants in an observational study that is assessed for biomedical or health outcomes.
Intervention / Treatment

Intervention / Treatment

A process or action that is the focus of a clinical study. Interventions include drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available. Interventions can also include noninvasive approaches, such as education or modifying diet and exercise.
control subjects
Other: cognitive skill, dual task and physical activity assessment
Montreal Cognitive Assessment Test, Trail Making Test (TMT) A & B sections and Stroop test for cognitive ability assessment, 10 meter walking test (single-double task) for dual task, Time up and Go test (single-double task), physical International Physical Activity Questionnaire was used for activity and The Exercise Benefit / Barriers Scale was used for exercise perception.
problematic video game player
Other: cognitive skill, dual task and physical activity assessment
Montreal Cognitive Assessment Test, Trail Making Test (TMT) A & B sections and Stroop test for cognitive ability assessment, 10 meter walking test (single-double task) for dual task, Time up and Go test (single-double task), physical International Physical Activity Questionnaire was used for activity and The Exercise Benefit / Barriers Scale was used for exercise perception.

What is the study measuring?

Primary Outcome Measures

Primary Outcome Measures

In a clinical study's protocol, the planned outcome measure that is the most important for evaluating the effect of an intervention/treatment. Most clinical studies have one primary outcome measure, but some have more than one.
Outcome Measure
Measure Description
Time Frame
International Physical Activity Questionnaire (IPAQ)
Time Frame: 1 days
It was used to evaluate the physical activities of individuals in the last week. It was also used to assess individuals' sedentary time.
1 days
The Exercise Benefits/Barriers Scale
Time Frame: 1 day
This scale is used to measure exercise benefit perception. a high score indicates the presence of positive exercise perception. High scores on this scale indicate that the perception of obstacles to exercise is at the forefront.
1 day
Montreal Cognitive Assessment Test
Time Frame: 1 day
Montreal Cognitive Assessment (MoCA) was developed as a rapid screening test for mild cognitive impairment.
1 day
Trail Making Test (TMT) A & B sections
Time Frame: 1 day
It is one of the neuropsychological tests widely used all over the world. TMT is a test that requires visual-spatial processing and motor skills, which measures executive functions such as working memory, complex attention, planning, and set changes.
1 day
Stroop Test
Time Frame: 1 day
It is a test that measures the ability to inhibition of inappropriate response in executive functions. It is a test that shows frontal functions that measures attention under a disruptive effect and evaluates to suppress inappropriate automatic responses.
1 day
10 meter walking test
Time Frame: 1 day
the 10-meter walking test, subjects are walked at their own normal speed and the walking time is measured with a stopwatch and recorded in m / sec. In the beginning, the 2-meter assembling phase is accepted as the 2-meter deceleration phase at the end of the walk, and measurement is made on a 14-meter-long track. In our study, normal walking speed and dual walking speed were measured and recorded separately, accompanied by dual tasks. In the evaluation of dual walking speed, individuals were asked to count animal names starting with the letter "K" and walking speed was recorded.
1 day
Timed Up & Go (TUG) test
Time Frame: 1 day
Timed Up & Go (TUG) test was used to evaluate functional mobility. Patients are asked to get up from the chair they are sitting in, walk 3 meters, turn back and sit on the chair again. Again, to evaluate the dual test, say words starting with the letter "N", the test is repeated and the time is recorded.
1 day

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Sponsor

The organization or person who initiates the study and who has authority and control over the study.
Çağtay Maden

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

Study Start

The actual date on which the first participant was enrolled in a clinical study. The "anticipated" study start date is the date that the researchers think will be the study start date.
January 1, 2020

Primary Completion (Actual)

Primary Completion

The date on which the last participant in a clinical study was examined or received an intervention to collect final data for the primary outcome measure. Whether the clinical study ended according to the protocol or was terminated does not affect this date. For clinical studies with more than one primary outcome measure with different completion dates, this term refers to the date on which data collection is completed for all the primary outcome measures. The "anticipated" primary completion date is the date that the researchers think will be the primary completion date for the study.
March 1, 2021

Study Completion (Actual)

Study Completion

The date on which the last participant in a clinical study was examined or received an intervention/treatment to collect final data for the primary outcome measures, secondary outcome measures, and adverse events (that is, the last participant's last visit). The "anticipated" study completion date is the date that the researchers think will be the study completion date.
March 29, 2021

Study Registration Dates

First Submitted

First Submitted

The date on which the study sponsor or investigator first submitted a study record to ClinicalTrials.gov. There is typically a delay of a few days between the first submitted date and the record's availability on ClinicalTrials.gov (the first posted date).
April 22, 2021

First Submitted That Met QC Criteria

First Submitted That Met QC Criteria

The date on which the study sponsor or investigator first submits a study record that is consistent with National Library of Medicine (NLM) quality control (QC) review criteria. The sponsor or investigator may need to revise and submit a study record one or more times before NLM's QC review criteria are met. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 22, 2021

First Posted (Actual)

First Posted

The date on which the study record was first available on ClinicalTrials.gov after National Library of Medicine (NLM) quality control (QC) review has concluded. There is typically a delay of a few days between the date the study sponsor or investigator submitted the study record and the first posted date.
April 27, 2021

Study Record Updates

Last Update Posted (Actual)

Last Update Posted

The most recent date on which changes to a study record were made available on ClinicalTrials.gov. There may be a delay between when the changes were submitted to ClinicalTrials.gov by the study's sponsor or investigator (the last update submitted date) and the last update posted date.
April 29, 2021

Last Update Submitted That Met QC Criteria

Last Update Submitted That Met QC Criteria

The most recent date on which the study sponsor or investigator submitted changes to a study record that are consistent with National Library of Medicine (NLM) quality control (QC) review criteria. It is the responsibility of the sponsor or investigator to ensure that the study record is consistent with the NLM QC review criteria.
April 27, 2021

Last Verified

Last Verified

The most recent date on which the study sponsor or investigator confirmed the information about a clinical study on ClinicalTrials.gov as accurate and current. If a study with a recruitment status of recruiting; not yet recruiting; or active, not recruiting has not been confirmed within the past 2 years, the study's recruitment status is shown as unknown.
April 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

Other Study ID Numbers

Identifiers or ID numbers other than the NCT number that are assigned to a clinical study by the study's sponsor, funders, or others. These numbers may include unique identifiers from other trial registries and National Institutes of Health grant numbers.
  • 2019/112

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Cookie Settings

We use cookies to ensure that we give you the best experience on our website. For more details carefully read our Privacy and Cookies Policy. ...>>>You can change your preferences or withdraw your consent at any time by deleting the cookies from your website or computer as described in the policy. Please accept it and choose your preferences by ticking the corresponding boxes in the "Manage Settings" section below. Please carefully read our Terms of Service before you proceed with using any part of this website.
«Manage Settings